Our Portfolio

Sun Capital Partners, Inc. is a trusted partner that is recognized for its investment and operational experience, including particular expertise in business and consumer services, healthcare, industrial and consumer sectors. Since 1995, Sun Capital has invested in more than 375 companies worldwide across a broad range of industries and transaction structures with revenues of approximately $50 billion.


NextPharma is one of the leading global providers of contract manufacturing, product development, clinical trials and logistics services to the pharmaceutical and biotechnology industries, offering both conventional technologies and specialist technologies.